Q4 2024 Kaya Ltd Earnings Call Transcript
Key Points
- Kaya Ltd (BOM:539276) reported a 24% revenue growth in its clinic business over Q4 FY23.
- Product business at clinics saw a 25% revenue growth, driven by categories like hair care, skin care, and nutraceuticals.
- Service business registered a 24% revenue growth, with body contouring showing a robust 77% growth over Q4 FY23.
- Customer count grew by 14% over Q4 FY23, aided by omnichannel routes.
- Clinic EBITDA improved from 21% in Q4 FY23 to 28% in Q4 FY24, reflecting better operational efficiency.
- Standalone profit-loss after tax (PAT) for Q4 FY24 was negative INR95 crores, impacted by a one-time cost of INR90 crores related to Middle East sales.
- Customer count in the Middle East declined by 3% versus Q4 FY23.
- The company has INR195 crores in total borrowings, which includes loans from directors and Kotak Bank.
- Despite growth in recent years, overall revenue has remained stagnant at INR400 crores since 2017.
- The company is planning a rights issue to raise funds, which may be seen as a negative by some investors due to the dilution of shares.
Ladies and gentlemen, good day and welcome to the Kaya Limited Q4 FY24 results conference call hosted by Dolat Capital Markets Private Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Sachin Bobade from Dolat Capital Markets Private Limited. Thank you, and over to you, sir.
Thank you, Lisan. On behalf of Dolat Capital, I welcome you all to the Q4 FY24 earnings conference call of Kaya Limited. Hope you all and your family members are staying safe and healthy. From the management side, we have with us Mr. Rajiv Suri, Global Chief Executive Officer and Managing Director, Kaya Middle East; Mr. Rajiv Nair, Chief Executive Officer, Kaya India; and Mr. Arihant Dhariwal, Chief Financial Officer. Now, I hand the floor to the management for their opening remarks and then we would have question-and-answer session. Over to you, sir.
Thank you.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
